🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0950
+0.0050 (5.56%)
Nov 20, 2026, 3:12 PM EST

Rapid Dose Therapeutics Revenue

Rapid Dose Therapeutics had revenue of 216.58K CAD in the quarter ending August 31, 2026, a decrease of -67.82%. This brings the company's total for the last twelve months to 2.12M, down -19.31% year-over-year. In the fiscal year ending February 28, 2026, Rapid Dose Therapeutics had annual revenue of 2.77M with 33.00% growth. That makes Rapid Dose Therapeutics the 42,967th largest company in the world by revenue and 864th in Canada.

Revenue (ttm)
2.12M
Revenue Growth
-19.31%
P/S Ratio
6.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 20262.77M688.14K33.00%
Feb 28, 20252.09M1.06M104.34%
Feb 29, 20241.02M302.13K42.06%
Feb 28, 2023718.30K-1.03M-59.00%
Feb 28, 20221.75M996.72K131.98%
Feb 28, 2021 Pro Pro Pro
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.